PPT-Developmental Monitoring, Screening, and Early Identification

Christy Kavulic Office of Special Education Programs Joan Danaher Frank Porter Graham Child Development Center Evelyn Shaw Frank Porter Graham Child Development Center DEC Conference. 2009-2012. . The Sooner We Start- The Farther They’ll Go!. . “. Early identification of developmental disorders is critical. . to the well-being of children and their families. It is an integral. the Early Identification of . Autism Spectrum Disorders. Corey Ray-Subramanian, PhD. Integrated Development Services. Learning objectives. Recognize . some early signs of ASD in toddlers. Identify .  tools and strategies for engaging families in developmental screening. Get in with the most dedicated and determined . early-adopters . Beat the crowds! Beat the box-office! Beat everyone but the truly dedicated film-fanatics that can’t bear to wait for the official release of the next big thing.. George E. Davis, MD . New Mexico Department of Children, Youth and Families. for. Child Trauma Academy. . Juvenile arrest rate highest ever in 1996 and then declined 48% by 2011. MALE AND FEMALE ARREST RATES—. Developmental Promotion, Screening and Early Detection, and Connecting to Services: . Celebrating Milestones and Sharing Concerns. PURPOSE:. . Promote . awareness and implementation of universal developmental monitoring, screening, and follow up in order to maximize young children’s development. . Developmental and Behavioral Screening and Support. Christy . Kavulic. , . EdD. . Office of Special Education . Programs. The Issue. 1. . in. . 4 children. , age 0-5 years, are at moderate or high risk for developmental, behavioral, or social delay. FAAP. Young Children with Autism Spectrum Disorder. Disclosures. Dr. Tridas is a speaker for:. Eli Lilly. Pfizer. Dr. Tridas is a consultant for:. Eli Lilly. Pfizer. Dr. Tridas has done research for:. FAAP. Young Children with Autism Spectrum Disorder. Disclosures. Dr. Tridas is a speaker for:. Eli Lilly. Pfizer. Dr. Tridas is a consultant for:. Eli Lilly. Pfizer. Dr. Tridas has done research for:. Royann Mraz, MD. Clinical Associate Professor Pediatrics. Center for Disabilities and Development. Dec 10, 2014. No conflicts of interest to disclose. Goals. Review developmental, autism, and social emotional screening. Supplemental Slides. Published March 26, 2020. 2016 ADDM Surveillance Summary Citations and Links. Maenner MJ, Shaw KA, Baio J, et al. Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disability Monitoring Network, 11 sites, United States, 2016. . Screening and Referral. Training . Slides . and . Notes . for . Minnesota’s . Public Screening Programs . and . Staff. Current as of November 2016. This . project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number H25MC00276 and title Early Childhood Comprehensive Systems (CISS SECCS) for grant amount $140,000. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. Collaborating to Promote Developmental Health of . Young Children. February 6, 2018. Julia Abercrombie, MPH, Behavioral Scientist. National Center on Birth Defects and Developmental Disabilities . Centers for Disease Control and Prevention. Division of Early Childhood 2020 Annual Conference. January 29, 2021. Betsey Howe, PhD, AUCD/CDC Fellow . Karnesha Slaughter, MPH, Health Communication Specialist, CDC . The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. 1. Cancer Screening Update IDCA MeetingSeptember 20, 20132. OverviewOntario’s Cancer Screening ProgramsOntario Breast Screening Program (OBSP)CR Mammography Technology Transition Project23. Ontario’s Cancer Screening ProgramsOntario Breast...